Separating Myths from Miracles in Electromagnetic healing Imagine walking through a health expo, surrounded by vendors promising the latest breakthroughs in wellness technology. “Recharge your cells with electromagnetic therapy!” one booth exclaims. “Cure pain instantly with PEMF!” another promises. But is there truth behind these claims? Can Pulsed Electromagnetic Field (PEMF) therapy truly heal the body at a cellular level, or is this just another health trend wrapped in flashy marketing? By Mike Van Thielen, PhD, Owner of Biohacking Unlimited Read More...https://lnkd.in/euCzxf7A #medhealthreview #biohackingunlimited
关于我们
Today’s healthcare horizon is not without challenges. However, the cumulative effort taken by thought leaders and experts is oriented toward understanding and leveraging limitless possibilities. Industry experts, medical professionals, and entrepreneurs are constantly on the lookout for solutions to enhance healthcare spending and management, utilization of resources, and overall improvement in ensuring the quality and safety of patient care. The industry is abuzz with activities. Medhealth Review is a monthly magazine focusing on the medical and healthcare industry. The magazine brings together reliable stories from the medical world that helps you stay ahead of the latest trends in the industry.
- 网站
-
https://www.medhealthreview.com
Medhealth Review的外部链接
- 所属行业
- 科技、信息和媒体
- 规模
- 11-50 人
- 总部
- New York,New York
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
New York Dr
US,New York,New York
Medhealth Review员工
动态
-
Telomeres and its functions Telomeres are fascinating structures that play a crucial role in maintaining the integrity of our genetic information. These protective caps, located at the ends of chromosomes, are composed of repetitive DNA sequences and associated proteins. Their primary function is to safeguard the ends of chromosomes from deterioration or fusion with neighboring chromosomes, which can lead to genetic instability and various diseases. By Abdul Alkayali, Vice President of Certified Nutraceuticals Read More...https://lnkd.in/gmGbHnAn #medhealthreview #CertifiedNutraceuticals
-
Valis Biosciences' Quest to Decode Measurement in Clinical Trials espite Valis’s achievement, their adventure is far from ended. We can’t help but be optimistic about the future as long as they keep coming up with new ideas, working together, and support ing a more sympathetic method of measurement and assessment in clinical trials and research studies. We’re getting closer to a society in which CNS disorders, such as mental illness, and rare and orphan disorders is accept ed with compassion and under standing rather than stigma tised or disregarded with Valis Biosciences leading the way. Christian Yavorsky, Chief Scientific Officer at Valis Bioscience Read More...https://lnkd.in/gGFm2Ayd #medhealthreview #ValisBioscience
-
An Award-Winning Solution Solving the Biggest Challenges in Clinical Trials In the fast-paced world of clinical trials, efficiency and precision are crucial. At Clinion, we’re proud to lead the charge with innovative technology that’s making a real difference. As someone deeply committed to advancing clinical research, I’m thrilled to share how our award-winning solutions are redefining trial management. By Manuj Vangipurapu, Founder Director at Clinion - eClinical Platform Read More...https://lnkd.in/g2feH2bB #medhealthreview #Clinion
-
DeepWell DTx announces FDA clearance that draws on video games and other interactive media to treat mental health DeepWell Digital Therapeutics (DTx), which commercializes immersive medical media for mental and physical health, today announced it has received 510(k) clearance from the Food and Drug Administration (FDA) on its biofeedback (ABS) software development kit (SDK) for use in over-the-counter treatments for the reduction of stress and as an adjunctive treatment for high blood pressure, together with other pharmacological and/or nonpharmacological interventions. By Jeffrey Tseng CEO at DeepWell DTx Read More...https://lnkd.in/gnfWZcAk #medhealthreview #deepwelldtx
-
Inside ProductionToGo’s Cutting-Edge Solutions Among other things, several new and advanced materials from our partners are currently in the f inal stages of the certification process for medical applications and we are already looking forward to offering these solutions to our customers Maximilian Neck, CEO at ProductionToGo GmbH Read More...https://lnkd.in/gGUkhM7x #medhealthreview #ProductionToGo
-
Reverba: Setting the Trend with Innovative Patient Engagement Strategies We bridge the gap between knowledge and empathy, using our years of experience and compliant high- and low-tech solutions. Cheryl Lubbert, Chief Executive Officer at Reverba Read More...https://lnkd.in/eUhYR3vd #medhealthreview #Reverba
-
Building Outpatient cashless services. Health insurance coverage for outpatient department (OPD) treatments typically includes medical costs for patients who do not require hospitalisation, such as expenses on consultations, diagnostic tests, and prescription drugs. By Shubhra Singh, Head - Customer Solutions of Medi Assist Read More...https://lnkd.in/gpMADD4c #medhealthreview #mediassist
-
Human Amniotic Membrane: Medical Trash to Medicinal Tool Excluding marsupials and monotremes, all mammals undergo three fundamental stages of birth: the onset of contractions, the birth of the infant, and the third stage known as “afterbirth,” which involves the expulsion of the placenta. Among the various components of the placenta, the amniotic membrane, often referred to as the amnion, is particularly significant. This thin yet resilient layer plays a crucial role in protecting and nourishing the fetus during pregnancy By Dr. Aaron J. Tabor, PhD, CTBS, CWCA, Chief Science Officer for Axolotl Biologix Read More...https://lnkd.in/g7XEMFc7 #medhealthreview #AxolotlBIologix
-
Ultimovacs Cancer Vaccine Faces Final Test After Third Failure Ultimovacs’ cancer vaccine UV1 has encountered another setback, failing in its third midphase clinical trial, this time targeting head and neck cancer. The trial, known as FOCUS, tested UV1 alongside Merck & Co.’s Keytruda in patients with metastatic or recurrent head and neck cancer. Read More...https://lnkd.in/gkRiUtDP